Maternal herpes simplex virus antibody avidity and risk of neonatal herpes - 18/08/11
Reprint requests: Anna Wald, MD, MPH, University of Washington Virology Research Clinic, 600 Broadway, Suite 400, Seattle, WA 98122.Abstract |
Objective |
The objective of the study was to assess whether herpes simplex virus antibody avidity is associated with risk of transmission of herpes simplex virus to the neonate.
Study design |
We developed a novel herpes simplex virus type 1 avidity test based on the commercially available Focus HerpeSelect-1 enzyme-linked immunosorbent assay kit using sera from nonpregnant subjects with genital herpes simplex virus-1 infection. We used this test, and the previously developed herpes simplex virus type 2 avidity test, to compare maternal herpes simplex virus-1 and herpes simplex virus-2 antibody avidity in women who transmitted herpes simplex virus to the neonate and women who had herpes simplex virus isolated from genital secretions at delivery but who did not transmit herpes simplex virus to their infants.
Results |
Among nonpregnant subjects with genital herpes simplex virus-1 infection whose sera were used to develop the herpes simplex virus-1 avidity test, a significant relationship between herpes simplex virus-1 antibody avidity and time since herpes simplex virus-1 acquisition was observed (P < .001, mixed-effects model), with median avidity values increasing over time after primary infection. Among pregnant, herpes simplex virus-1, or herpes simplex virus-2 seropositive women, 4 of 8 women (50%) with avidity 40 or greater transmitted herpes simplex virus to the neonate, compared with only 12 of 97 (12%) of women with avidity greater than 40 (P = .02).
Conclusions |
Herpes simplex virus-1 antibody avidity increased over time after genital herpes simplex virus-1 acquisition, as has been previously observed for herpes simplex virus-2. Among women with herpes simplex virus antibody at delivery, low antibody avidity was associated with herpes simplex virus transmission to the neonate and may be a useful marker for recent seroconversion.
Le texte complet de cet article est disponible en PDF.Key words : Neonatal herpes, Avidity
Plan
| Supported by National Institutes of Health Grant AI30731 (to R.M., E.K., L.C., and A.W.) and National Institutes of Health Training Grant T32 AI07140 (to E.B.). |
Vol 195 - N° 1
P. 115-120 - juillet 2006 Retour au numéro
Article précédent
- Nasal bone in first-trimester screening for trisomy 21
- Simona Cicero, Kyriaki Avgidou, Georgios Rembouskos, Karl Oliver Kagan, Kypros H. Nicolaides
- Labor dystocia and its association with interpregnancy interval
- Bao-Ping Zhu, Violanda Grigorescu, Thu Le, Mei Lin, Glenn Copeland, Maurice Barone, George Turabelidze
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?